ACE rs1800764: Understanding This Genetic Variant
The rs1800764 variant is a genetic change located within the ACE gene, which encodes the angiotensin-converting enzyme. Research has investigated its potential association with variations in soluble amyloid-beta levels in individuals diagnosed with Alzheimer's disease.
What each genotype means
Typical ACE variant profile
This genotype is one of the common variations found in the ACE gene. Research into this variant has explored its potential link to amyloid-beta levels and late-onset Alzheimer's disease risk, though findings across different populations have been inconsistent and often show no significant association. This variant does not provide a diagnostic result, and any concerns regarding cognitive health should be discussed with a healthcare professional.
This is a common genotype found globally, though exact frequencies vary significantly by ancestral background.
Typical ACE variant profile
This genotype represents a heterozygous state for this ACE gene variant. While some studies have investigated whether this variant influences cerebrospinal fluid amyloid-beta levels or Alzheimer's disease risk, results remain mixed and inconclusive across various ethnic groups. This information is for educational purposes and should not be used to predict individual health outcomes.
This is a common genotype found globally, though exact frequencies vary significantly by ancestral background.
Typical ACE variant profile
This genotype is a common variation within the ACE gene. Scientific literature has examined this variant for potential associations with Alzheimer's disease pathology, but large-scale studies have frequently failed to replicate initial findings of a strong risk association. This result is not a medical diagnosis, and you should consult with a clinician regarding any personal health concerns.
This is a common genotype found globally, though exact frequencies vary significantly by ancestral background.
What is rs1800764?
The variant rs1800764 is a single nucleotide polymorphism (SNP) situated in the promoter and 5' untranslated region of the ACE gene. SNPs are the most common type of genetic variation among people, representing a difference in a single DNA building block, or nucleotide. Because this specific variant is located in a regulatory region of the gene, researchers have long hypothesized that it may influence how much ACE protein is produced by the body. By studying this location, scientists aim to understand how subtle changes in our genetic code might contribute to complex biological processes, such as the regulation of proteins involved in neurodegenerative conditions.
The Role of the ACE Gene
The ACE gene provides instructions for making the angiotensin-converting enzyme. This enzyme plays a critical role in the renin-angiotensin system, which helps regulate blood pressure and fluid balance in the body. Beyond its cardiovascular functions, ACE is also involved in the breakdown of various peptides. In the context of neurological research, scientists have focused on the enzyme's ability to degrade amyloid-beta, a protein that can accumulate in the brains of individuals with Alzheimer's disease. Because ACE is involved in these metabolic pathways, variations in the gene that alter its expression or activity levels are considered plausible candidates for influencing the risk or progression of Alzheimer's disease.
Research and Evidence Strength
Evidence linking rs1800764 to Alzheimer's disease is considered moderate and often mixed. Some studies have reported that this variant, along with others in the ACE gene, shows a statistical association with levels of soluble amyloid-beta in the cerebrospinal fluid of patients with Alzheimer's disease. However, other large-scale studies have failed to find a consistent, significant association between this specific SNP and the overall risk of developing late-onset Alzheimer's disease. The complexity of the disease, which involves many genetic and environmental factors, makes it difficult to isolate the effect of a single variant. Consequently, while rs1800764 remains a subject of scientific interest, it is not currently used as a definitive diagnostic or predictive marker in clinical practice.
Population Frequency
The rs1800764 variant is considered a common genetic polymorphism. It is found across diverse ancestral populations, though the specific frequency of the different alleles can vary depending on the population group being studied. Because it is a common variant, it is present in a significant portion of the general population, which is why it has been frequently included in large-scale genome-wide association studies (GWAS) aimed at identifying genetic contributors to common health conditions.
Interpreting Genetic Information
It is important to understand that having a particular genotype for rs1800764 does not mean an individual will develop a specific condition. Genetic associations observed in research studies represent statistical trends across large groups of people, not individual medical predictions. If you have questions about your genetic results or concerns regarding Alzheimer's disease, you should discuss them with a qualified healthcare provider or a genetic counselor. They can help you interpret your information in the context of your personal and family medical history. Never use genetic data to make medical decisions or change medications without consulting your clinician or pharmacist, as they are the only ones who can provide appropriate medical guidance.
How common is this variant?
The rs1800764 variant is a common polymorphism found across various global populations, with its specific allele frequencies varying by ancestry.
Frequently asked questions
Does rs1800764 cause Alzheimer's disease?
No, rs1800764 is not a cause of Alzheimer's disease. It is a genetic variant that has been studied for its potential association with the disease, but it does not determine whether an individual will develop the condition.
Should I get tested for this variant?
There is no clinical recommendation to test for this variant. Because the evidence regarding its impact is mixed and it is not a diagnostic marker, it is not used in routine medical care.
Can I change my risk based on my genotype?
Genetic variants like rs1800764 are fixed at birth. While you cannot change your genotype, you should focus on established lifestyle factors that support brain health, such as regular exercise, a balanced diet, and cognitive engagement, in consultation with your doctor.
Where can I find more information on ACE variants?
You can explore resources like the GWAS Catalog or PubMed to find peer-reviewed research on ACE variants. Always ensure you are looking at reputable scientific databases rather than speculative health websites.
Sources & further reading
Educational information only, last refreshed 10/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800764?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ACE
This SNP is being investigated as a potential biomarker for personalized antihypertensive therapy in specific ethnic cohorts.
A variant recently evaluated in pharmacogenomic studies of the Pashtun population to assess its role in antihypertensive drug response.
Exonic proxy marker for the ACE insertion/deletion polymorphism affecting circulating ACE enzyme activity and cardiovascular phenotypes.
Coding-region single nucleotide variant in the angiotensin-converting enzyme gene investigated for modulation of baseline exercise test duration and cardiovascular training response.
Functional polymorphism influencing angiotensin-converting enzyme activity levels and blood pressure response to ACE inhibitor therapy.